{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:30:10Z","timestamp":1762252210517},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":947,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1593\/neo.11576","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:11:02Z","timestamp":1429794662000},"page":"912-IN17","source":"Crossref","is-referenced-by-count":28,"title":["Elucidating the Mechanism of Regulation of Transforming Growth Factor \u03b2 Type II Receptor Expression in Human Lung Cancer Cell Lines"],"prefix":"10.1016","volume":"13","author":[{"given":"Sunil K.","family":"Halder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jig","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunima","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govindaraj","family":"Anumanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy-Joan L.","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pran K.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1593\/neo.11576_bib1","first-page":"2718","article-title":"Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers","volume":"56","author":"Nagatake","year":"1996","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib2","first-page":"5583","article-title":"Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers","volume":"56","author":"Uchida","year":"1996","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib3","first-page":"8331","article-title":"Heterogeneous transforming growth factor (TGF)-\u03b2 unresponsiveness and loss of TGF-\u03b2 receptor type II expression caused by histone deacetylation in lung cancer cell lines","volume":"61","author":"Osada","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6690161","article-title":"Inactivation of the transforming growth factor \u03b2 type II receptor in human small cell lung cancer cell lines","volume":"79","author":"Hougaard","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1593\/neo.11576_bib5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/sj.bjc.6602831","article-title":"Restoration of TGF-\u03b2 signalling reduces tumorigenicity in human lung cancer cells","volume":"93","author":"Anumanthan","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1593\/neo.11576_bib6","doi-asserted-by":"crossref","first-page":"29460","DOI":"10.1074\/jbc.270.49.29460","article-title":"Characterization of the promoter region of the human transforming growth factor-\u03b2 type II receptor gene","volume":"270","author":"Bae","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.11576_bib7","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1038\/sj.onc.1204808","article-title":"Regulation of the human transforming growth factor \u03b2 type II receptor gene promoter by novel Sp1 sites","volume":"20","author":"Jennings","year":"2001","journal-title":"Oncogene"},{"key":"10.1593\/neo.11576_bib8","doi-asserted-by":"crossref","first-page":"21115","DOI":"10.1074\/jbc.273.33.21115","article-title":"Transcriptional activation of the type II transforming growth factor-\u03b2 receptor gene upon differentiation of embryonal carcinoma cells","volume":"273","author":"Kelly","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.11576_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/70611","article-title":"Repression of the gene encoding the TGF-\u03b2 type II receptor is a major target of the EWS-FLI1 oncoprotein","volume":"23","author":"Hahm","year":"1999","journal-title":"Nat Genet"},{"key":"10.1593\/neo.11576_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1593\/neo.11576_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.11576_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001813-200201000-00001","article-title":"Histone deacetylase inhibitors in cancer treatment","volume":"13","author":"Vigushin","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1593\/neo.11576_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","article-title":"Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes","volume":"7","author":"Kim","year":"2001","journal-title":"Nat Med"},{"key":"10.1593\/neo.11576_bib14","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","article-title":"A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors","volume":"96","author":"Saito","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.11576_bib15","first-page":"931","article-title":"MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor \u03b2 type II receptor expression in human breast cancer cells","volume":"61","author":"Lee","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib16","first-page":"6108","article-title":"MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors","volume":"62","author":"Jaboin","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yexcr.2005.03.009","article-title":"Smad7 induces tumorigenicity by blocking TGF-\u03b2-induced growth inhibition and apoptosis","volume":"307","author":"Halder","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1593\/neo.11576_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1593\/neo.04640","article-title":"A specific inhibitor of TGF-\u03b2 receptor kinase, SB-431542, as a potent antitumor agent for human cancers","volume":"7","author":"Halder","year":"2005","journal-title":"Neoplasia"},{"key":"10.1593\/neo.11576_bib19","first-page":"2624","article-title":"Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor \u03b2 type II receptor expression in human pancreatic cancer cells","volume":"63","author":"Zhao","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/pr0604054","article-title":"MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis","volume":"6","author":"Tabb","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1593\/neo.11576_bib21","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/pr070230d","article-title":"Proteomic parsimony through bipartite graph analysis improves accuracy and transparency","volume":"6","author":"Zhang","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1593\/neo.11576_bib22","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1021\/pr900360j","article-title":"IDPicker 2.0: improved protein assembly with high discrimination peptide identification filtering","volume":"8","author":"Ma","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1593\/neo.11576_bib23","first-page":"6206","article-title":"Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-5002(03)00225-3","article-title":"Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)","volume":"41","author":"Mukohara","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1593\/neo.11576_bib25","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.1073\/pnas.250494697","article-title":"Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras","volume":"97","author":"Zhou","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.11576_bib26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/0008-5472.CAN-05-1988","article-title":"Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines","volume":"66","author":"Witta","year":"2006","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11576_bib27","doi-asserted-by":"crossref","first-page":"14553","DOI":"10.1073\/pnas.94.26.14553","article-title":"Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1","volume":"94","author":"Knoepfler","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.11576_bib28","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/MCB.19.8.5504","article-title":"Histone deacetylase 1 can repress transcription by binding to Sp1","volume":"19","author":"Doetzlhofer","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1593\/neo.11576_bib29","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1074\/jbc.M106451200","article-title":"Transcriptional regulation of the transforming growth factor \u03b2 type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells","volume":"277","author":"Park","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.11576_bib30","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1074\/jbc.M408680200","article-title":"Trichostatin A induces transforming growth factor \u03b2 type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF\/p300 to a Sp1.NF-Y complex","volume":"280","author":"Huang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.11576_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780903382609","article-title":"Targeting the transforming growth factor-\u03b2 signaling pathway in human cancer","volume":"19","author":"Nagaraj","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1593\/neo.11576_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nrd1580","article-title":"Development of TGF-\u03b2 signalling inhibitors for cancer therapy","volume":"3","author":"Yingling","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1593\/neo.11576_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrc1208","article-title":"Cytostatic and apoptotic actions of TGF-\u03b2 in homeostasis and cancer","volume":"3","author":"Siegel","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.11576_bib34","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI0215234","article-title":"Blockade of TGF-\u03b2 inhibits mammary tumor cell viability, migration, and metastases","volume":"109","author":"Muraoka","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1593\/neo.11576_bib35","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1172\/JCI200215333","article-title":"Lifetime exposure to a soluble TGF-\u03b2 antagonist protects mice against metastasis without adverse side effects","volume":"109","author":"Yang","year":"2002","journal-title":"J Clin Invest"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:27:20Z","timestamp":1537687640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558611800795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1476558611800795"],"URL":"https:\/\/doi.org\/10.1593\/neo.11576","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}